Vimarsana
Biggest News Aggregation in the World

Lease Visit Https Venusmedtechconference Com News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lease Visit Https Venusmedtechconference Com . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lease Visit Https Venusmedtechconference Com Today - Breaking & Trending Today

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023 - Vimarsana News

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

Published: November 20, 2023

The company will be presenting its growing pipeline of superb technologies for treating all four heart valves in its booth and at multiple events during the conference. HANGZHOU, China, Nov. 20, 2023 /PRNewswire/ -- Venus Medtech is changing how the world treats structural heart disease. The company will present its products at its booth (#28), during two symposia, in multiple podium presentations and at a special cocktail reception where it will officially launch the SMART-ALIGN multicenter clinical study. Structural heart symposia on November 20 and 21 The company will be hosting two symposi...

Source: singaporestar.com
Related Topics:
City OfUnited KingdomPrnewswire Venus MedtechVenus MedtechVenus Vitae Transcatheter Heart Valve SystemLondon ValvesThe Company Will Be Presenting Its Growing Pipeline Of Superb Technologies For Treating All Four Heart Valves In Booth And At Multiple Events During Conference HangzhouNov 20023 Prnewswire Venus Medtech Is Changing How The World Treats Structural Heart Disease Company Will Present Its Products At Booth 28 Uring Two SymposiaN Multiple Podium Presentations And Ata Special Cocktail Reception Where It Will Officially Launch The Smart Align Multicenter Clinical Study Structural Heart Symposia On November 20 21 Company Be Hosting Two That Allow Interventional Cardiologists To Deepen Their Knowledge About Interventions FirstUot Valve Tricuspid Transcatheter Cardiovalve Keeps It In Motion Quot Will Be Dedicated To Discussing The Latest Results And Future Plans For Replacement System SecondUot Addressing Remaining Issues After Tavi What To Expect From The New GenerationUot Presenters Will Focus On The Tools And Techniques Showcasing Venus Vitae Launching Smart Align Study With Registration Studies Commencing Annually AdditionallyEnus Will Be Officially Launching The Smart Align Study To Evaluate Performance Of Venus Vitae Transcatheter Heart Valve System In Patients With Severe Aortic Stenosis Enroll 150 At 20 Medical Centers Worldwide This New Builds On Target Launched London Valves 2022Hich Is Evaluating The Cardiovalve System For Transcatheter Tricuspid Valve Replacement Now On Track Ce Mark Approval In Late 2026Ith About Half Of The Patients Already Enrolled Prior To ThisEnus Medtech Achieved Significant Success With Its Pvalve System Replacing The Pulmonary ValveEcuring Ce Approval In 2022 And Planning For An Fda Registration Study 2024 These Studies Area Testament To Venus Medtech 39s MissionOnsistently Improving The Treatment Of Structural Heart Disease About Venus Medtech Hangzhou Inc 2500 Hk Is Committed To Innovation We Are Developing And Commercializing Comprehensive Solutions For Our Robust PipelineNcompassing All Four Heart Valves From TavrNd Ttvr To Hypertrophic Cardiomyopathy And Hypertensive Renal Denervation Rdn TherapyNderscores Our Unwavering Commitment For More InformationLease Visit Https Venusmedtechconference Com